14
Views
5
CrossRef citations to date
0
Altmetric
Invited Papers

Redo Valve Surgery Nowadays: What Have we Learned ?

, , &
Pages 475-480 | Published online: 14 Mar 2016

References

  • Biglioli P., Di Matteo S., Parolari A., Antona C., Arena V., Sala A. Re-operative cardiac valve surgery: a multivariable analysis of risk factors. Cardiovasc Surg, 1994, 2 (2): p. 216–22.
  • Cohn L. H., Aranki S. F., Rizzo R. J. et al. Decrease in operative risk of re-operative valve surgery. Ann Thorac Surg, 1993, 56 (1): p. 15–20; discussion 20–1.
  • Pansini S., Ottino G., Forsennati P. G. et al. Re-operations on heart valve prostheses: an analysis of operative risks and late results. Ann Thorac Surg, 1990, 50 (4): p. 590–6.
  • Magovern J. A., Sakert T., Benckart D. H. et al. A model for predicting transfusion after coronary artery bypass grafting. Ann Thorac Surg, 1996, 61 (1): p. 27–32.
  • Ottino G., De Paulis R., Pansini S. et al. Major sternal wound infection after open-heart surgery: a multivariate analysis of risk factors in 2,579 consecutive operative procedures. Ann Thorac Surg, 1987, 44 (2): p. 173–9.
  • Valla J., Corbineau H., Langanay T. et al. [Mediastinitis after cardiac surgery. A 10-year evaluation (1985–1995)]. Ann Cardiol Angeiol (Paris), 1996, 45 (7): p. 369–76.
  • Macartney F. J., Scott O., Ionescu M. I. Late haemodynamic results of fascia lata reconstruction of the right ventricular outlet. Am Heart J, 1975, 89 (2): p. 195–9.
  • Senning A., Rothlin M. The late fate of autologous fascia lata valve grafts in the aortic position. Isr J Med Sci, 1975, 11 (2–3): p. 179–84.
  • Magilligan D. J. Jr., Lewis J. W. Jr., Tilley B., Peterson E. The porcine bioprosthetic valve. Twelve years later. J Thorac Cardiovasc Surg, 1985, 89 (4): p. 499–507.
  • Foster A. H., Greenberg G. J., Underhill D. J., McIntosh C. L., Clark R. E. Intrinsic failure of Hancock mitral bioprostheses: 10-to 15-year experience. Ann Thorac Surg, 1987, 44 (6): p. 568–77.
  • Akins C. W., Carroll D. L., Buckley M. J., Daggett W. M., Hilgenberg A. D., Austen W. G. Late results with Carpentier-Edwards porcine bioprosthesis. Circulation, 1990, 82 (5 Suppl): p. iV65–74.
  • Pelletier L. C., Carrier M., Leclerc Y., Lepage G., deGuise P., Dyrda I. Porcine versus pericardial bioprostheses: a comparison of late results in 1,593 patients. Ann Thorac Surg, 1989, 47 (3): p. 352–61.
  • Kawachi Y., Matuzaki K., Tominaga R., Yasui H., Tokunaga K. The risks of re-operation for prosthetic valve dysfunction. Surg Today, 1994, 24 (5): p. 415–9.
  • Pellerin M., Mihaileanu S., Couetil J. P. et al. Carpentier-Edwards pericardial bioprosthesis in aortic position: long-term follow-up 1980 to 1994. Ann Thorac Surg, 1995, 60 (2 Suppl): p. S292-5; discussion S295–6.
  • Tyers G. F., Jamieson W. R., Munro A. I. et al. Re-operation in biological and mechanical valve populations: fate of the re-operative patient. Ann Thorac Surg, 1995, 60 (2 Suppl): p. S464–8; discussion S468–9.
  • Antunes M. J., Magalhaes M. P. Isolated replacement of a prosthesis or a bioprosthesis in the mitral valve position. Am J Cardiol, 1987, 59 (4): p. 346–9.
  • Caus T., Mesana T., Mouly A., Guez P., Tapia M., Monties J. R. [Repeated heart valve replacements: prognosis and results]. Arch Mal Coeur Vaiss, 1995, 88 (1): p. 35–41.
  • Cohn L. H., Koster J. K. Jr., VandeVanter S., Collins J. J. Jr. The in-hospital risk of re-replacement of dysfunctional mitral and aortic valves. Circulation, 1982, 66 (2 Pt 2): p. i153–6.
  • Husebye D. G., Pluth J. R., Piehler J. M. et al. Re-operation on prosthetic heart valves. An analysis of risk factors in 552 patients. J Thorac Cardiovasc Surg, 1983, 86 (4): p. 543–52.
  • Terada Y., Wanibuchi Y., Takagi H., Shimoyama Y., Ino T., Furuta S. [Report of 108 patients with valvular heart disease who underwent re-operations through repeated median sternotomy incision]. Kyobu Geka, 1989, 42 (6): p. 426–30, discussion 4313.
  • Bortolotti U., Milano A., Mossuto E., Mazzaro E., Thiene G., Casarotto D. Early and late outcome after re-operation for prosthetic valve dysfunction: analysis of 549 patients during a 26-year period. J Heart Valve Dis, 1994, 3 (1): p. 81–7.
  • David T. E. Re-operations on the aortic valve combined with replacement of the ascending aorta. J Card Surg, 2001, 17 (1): p. 46–50.
  • Beghi C., De Cicco G., Nicolini F., Ballore L., Reverberi C., Gherli T. Cardiac valve re-operations: analysis of operative risk factors in 154 patients. J Heart Valve Dis, 2002, 11 (2): p. 25862.
  • Cohn L. H., Peigh P. S., Sell J., DiSesa V. J. Right thoracotomy, femorofemoral bypass, and deep hypothermia for re-replacement of the mitral valve. Ann Thorac Surg, 1989, 48 (1): p. 69–71.
  • Nashef S.A., Roques F., Michel P., Gauducheau E., Lemeshow S., Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg, 1999, 16 (1): p. 9–13.
  • Merlo C., Aidala E., La Scala E. et al. Mortality and morbidity in re-operation compared with first intervention in coronary revas-cularization. J Cardiovasc Surg (Torino), 2001, 42 (6): p. 713–7.
  • Fundaro P., Santoli C. Towards an easier and safer re-operation of the atrioventricular valves: the right anterolateral thoracotomy approach without pericardial dissection. J Cardiovasc Surg (Torino), 1989, 30 (5): p. 779–81.
  • Yaginuma G., Ottomo M., Abe K. et al. Mitral exposure technique for redo cardiac surgery. A left mediastinal pleurotomy and minimal adhesiotomy method. J Cardiovasc Surg (Torino), 2001, 42 (4): p. 501–3.
  • Diehl J. T., Eichhorn E. J., Konstam M. A. et al. Efficacy of retrograde coronary sinus cardioplegia in patients undergoing myocardial revascularization: a prospective randomized trial. Ann Thorac Surg, 1988, 45 (6): p. 595–602.
  • Eichhorn E. J., Diehl J. T., Konstam M. A., Payne D. D., Salem D. N., Cleveland R. J. Protective effects of retrograde compared with antegrade cardioplegia on right ventricular systolic and diastolic function during coronary bypass surgery. Circulation, 1989, 79 (6): p. 1271–81.
  • Sirivella S., Gielchinsky I., Parsonnet V. Management of catheter-induced pulmonary artery perforation: a rare complication in cardiovascular operations. Ann Thorac Surg, 2001. 72(6): p. 2056–9.
  • Wang M. J., Chen T. L., Huang C. H., Chao A., Chu S. H. Difference in efficacy of the Cell Saver in coronary bypass grafting surgery and cardiac valvular re-operations. J Formos Med Assoc, 1994, 93 (2): p. 117–21.
  • Royston D., Bidstrup B. P., Taylor K. M., Sapsford R. N. Effect of aprotinin on the need for blood transfusion after repeat open-heart surgery. Lancet, 1987, 2 (8571): p. 1289–91.
  • Bidstrup B. P., Royston D., Sapsford R. N., Taylor K. M. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). J Thorac Cardiovasc Surg, 1989. 97 (3): p. 364–72.
  • Dobell A. R., Jain A. K. Catastrophic haemorrhage during redo sternotomy. Ann Thorac Surg, 1984, 37 (4): p. 273–8.
  • O’Brien M.F., Harrocks S., Clarke A., Garlick B., Barnett A.G. How to do safe sternal re-entry and the risk factors of redo cardiac surgery: a 21-year review with zero major cardiac injury. J Card Surg, 2002, 17 (1): p. 4–13.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.